CN / EN
联系我们
KYKJT
LL-37(17-32)

LL-37(17-32)

  • 80%,90%,95%,98%,99%
  • 询价

LL-37 (17-32) 是一种 ABCG2 抑制剂。LL-37 (17-32) 可与 ABCG2 结合,以非竞争性方式抑制其转运活性,并通过溶酶体降解下调 ABCG2 蛋白表达。LL-37 (17-32) 可增加米托蒽醌 (Mitoxantrone) (HY-13502) 在过表达 ABCG2 的癌细胞内的蓄积,从而逆转米托蒽醌耐药性。LL-37 (17-32) 可用于多药耐药癌症的研究。

产品信息

产品名称LL-37(17-32)
产品描述LL-37 (17-32) is an ABCG2 inhibitor. LL-37 (17-32) binds to ABCG2, inhibits its transport activity in a non-competitive manner, and downregulates ABCG2 protein expression through lysosomal degradation. LL-37 (17-32) increases the accumulation of mitoxantrone (HY-13502) in ABCG2-overexpressing cancer cells, thereby reversing mitoxantrone resistance. LL-37 (17-32) can be used in research on multidrug-resistant cancers.
生物活性LL-37 (17-32) is an ABCG2 inhibitor. LL-37 (17-32) binds to ABCG2, inhibits its transport activity in a non-competitive manner, and downregulates ABCG2 protein expression via lysosomal degradation. LL-37 (17-32) increases the accumulation of Mitoxantrone (HY-13502) in cancer cells overexpressing ABCG2, thereby reversing mitoxantrone resistance. LL-37 (17-32) can be used in the research of multidrug-resistant cancers.
CAS号717919-61-4
性状Solid
颜色White to off-white
序列Phe-Lys-Arg-Ile-Val-Gln-Arg-Ile-Lys-Asp-Phe-Leu-Arg-Asn-Leu-Val
序列缩写FKRIVQRIKDFLRNLV
储存方式Sealed storage, away from moisture
上一个:
Daptomycin
下一个:
LL-37, human
置顶